Text with Title
Evaluate gives you the understanding and time you need to drive better decisions.
Evaluate’s transparent aggregation of the latest commercial analysis means you can use one single source as the basis of the best strategic advice. Get quick and easy access to global and regional market assessments, trends in therapeutic areas, competitor analysis and commercial due diligence.
Be the expert your clients turn to for trusted advice
- Identify risk and evaluate potential assets earlier in the screening process
- Quickly create overviews of different therapeutic areas with comprehensive information on key players, market size and analysis of growth and pipeline
- Understand target markets, key players, launch timings and patent expiry timelines
- Run detailed company overviews, detailing growth drivers and brakes, upcoming launches, peak sales data, patents, pipeline analysis and in-depth financial forecasts
Be confident you’re providing the right recommendations
- Present a comprehensive competitive R&D landscape for client decision-making
- Benchmark your client’s R&D performance versus competitors
- Rely on transparent methodologies and datasets linked to source information
- Benchmark your internal forecasts against analogue
- Cut your prep time for client meetings with high level reports consolidating a huge range of datasets to quickly understand market dynamics and challenges for your clients
- Reduce your research time with predefined consensus forecasts for markets and companies
- Quickly build your own customised reports to share with internal teams
Find out how Evaluate can help you
“ Evaluate is one of the few sources I've seen that integrates the life science focus with commercial data on clinical pipelines, drug phases, product characteristics, and more. It gives us the ability to view everything in one place. ”
Vishwas S, Vice President, Bank of America
“ Evaluate’s extensive data classifications make it a powerful tool for anyone to easily access information. It contains a detailed search and many of its reports can be personally customised, which makes the platform very user-friendly. ”
Motomu Himori, Specialist, Chugai Pharmaceutical Co., Ltd.